MCRPC
Clinical trials for MCRPC explained in plain language.
Never miss a new study
Get alerted when new MCRPC trials appear
Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Half the dose, same hope? trial tests cutting hormone therapy in prostate cancer
Disease control Not yet recruitingThis phase 3 trial is testing whether giving men with metastatic prostate cancer half the standard dose of certain hormone therapies (called ARPIs) can be just as effective as the full dose, while causing less fatigue and fewer treatment stoppages. About 1,500 men with prostate c…
Matched conditions: MCRPC
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for tough prostate cancer: experimental combo targets resistant tumors
Disease control Not yet recruitingThis early-stage study tests a new drug (LC-K76) combined with an immunotherapy (Tislelizumab) and hormone therapy in 10 men with metastatic castration-resistant prostate cancer that has worsened after standard treatments. The goal is to check safety and see if the combination ca…
Matched conditions: MCRPC
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC